All Programs are accredited by Ministry of Education, UAE. RAK College of Medical Sciences is listed in the World Directory of Medical Schools(WDOMS)

Dr. Syed Arman Rabbani

Associate Professor



Follow on

Educational Qualifications:
  • PhD, Pharmaceutical Medicine: Ranbaxy Research Laboratories in collaboration with Jamia Hamdard University, New Delhi, India (2014)
  • M.Pharm Pharmacology: Jamia Hamdard Univeristy, New Delhi, India (2010)
  • B.Pharm: Jamia Hamdard University, New Delhi, India (2008)
  • Intellectual Property Course – World Intellectual Property Organization (WIPO) Worldwide Academy
Professional Career:
  • Associate Professor, Department of Clinical Pharmacy & Pharmacology, RAK College of Pharmaceutical Sciences, Ras Al Khaimah, UAE (November 2019 to till date)
  • Assistant Professor, Department of Clinical Pharmacy & Pharmacology, RAK College of Pharmaceutical Sciences, Ras Al Khaimah, UAE (October 2014 to October 2019)
  • Faculty, Centre for Translational and Clinical Research, Jamia Hamdard University, New Delhi, India (June 2014 to September 2014)
  • Assistant Manager, Medical and Scientific Department, Max Neeman International, New Delhi, India (December 2013 to June 2014) 
  • Lecturer cum Consultant, Creo Zenith Health, Noida, India (April 2012 to April 2013)
  • Lecturer, Institute of Clinical Research India, New Delhi, India (March 2011 to March 2012)
  • Research Associate, Research and Development Unit, Ranbaxy Research Laboratories, India (June 2010 to September 2010)
Research Interests:
  • Holistic, collaborative, interdisciplinary approach towards research
  • Involved in Pre-clinical, clinical and community based research
  • Clinical: Renal and cardiovascular clinical pharmacy and pharmacology related research
  • Pre-clinical: Pharmacokinetic and pharmacodynamic evaluation of drug formulations and natural products
  • Community: Community based educational intervention research
Publications:

Number of Publications: 35

Recent Publications
  • Prevalence and associations of moderately increased albuminuria in patients with type 2 diabetes in United Arab Emirates. Diabetes & Metabolic Syndrome.
  • Evaluation of antihypertensive prescriptions for rationality and adherence to treatment guidelines: An experience from United Arab Emirates. Clinical Epidemiology and Global Health. 
  • Prescription pattern of antihypertensive drugs: An experience from a secondary care hospital in the United Arab Emirates. Journal of Research in Pharmacy Practice.
  • Use of phosphate binders in end-stage renal disease: An experience from a secondary care hospital in United Arab Emirates. Journal of Pharmacy and Bioallied Sciences.
  • Impact of community based educational intervention on antibiotic use and resistance awareness among the people living in Ras Al Khaimah, United Arab Emirates. Journal of Pharmaceutical Health Services Research.
  • Impact of community-based educational intervention on breast cancer and its screening awareness among Arab women in the United Arab Emirates. Clinical Epidemiology and Global Health
  • Intensive Monitoring of Adverse Drug Reactions to Antiepileptic Drugs in Neurology Department of a Secondary Care Hospital in U.A.E. Journal of Young Pharmacists
  • Facile functionalization of Teriflunomide-loaded nanoliposomes with Chondroitin sulphate for the treatment of Rheumatoid arthritis. Carbohydrate Polymers. (Impact Factor: 7.18)
  • Nanotechnology Driven Approaches for the Management of Parkinson’s Disease: Current Status and Future Perspectives. Current Drug Metabolism. (Impact Factor: 2.92)
  • Quality by Design driven development and optimization of teriflunomide loaded nanoliposomes for treatment of rheumatoid arthritis: An in vitro and in vivo assessments. Journal of Drug Delivery Science and Technology. (Impact Factor: 2.7)
  • Biocompatible Nanovesicular Drug Delivery Systems with Targeting Potential for Autoimmune Diseases. Current Pharmaceutical Design. (Impact Factor: 2.4)
Achievements/Awards: (Recent)
  • Young Teacher Award by Society of Pharmaceutical Education & Research for outstanding contribution towards pharmaceutical education & research to be given on 3rd October 2019 in Bangkok
  • Best Poster Presentation Award for research paper titled “Evaluation of Antihypertensive Prescriptions for Rationality and Adherence to Treatment Guidelines: An Experience from a Secondary Care Hospital in United Arab Emirates” at the SPER International Conference 2019 in Bangkok, Thailand
  • Special Prize at Student Scientific Conference 2019, RAK Medical and Health Sciences, UAE.  Hammoud KM, BS Sridhar SB, Rabbani SA, Kurian MT. Assessment and Evaluation of Potential Drug-Drug Interactions and Adverse Drug Reactions among Chronic Kidney Disease Patients of a Secondary Care Hospital of Ras Al Khaimah
  • Best Oral Presentation Award at DUPHAT 2019, Dubai, UAE for supervised research. AbuDawoud GS, Bara MM, Younes MA. Rabbani SA. Implementation of artificial intelligence (AI) in healthcare.
  • Best Quality Poster Award at DUPHAT 2018, Dubai, UAE for supervised research. Marzooqi ASMK, Srouji AEM, Hamad EA, Rabbani SA. Impact of community-based educational intervention on breast cancer and its screening awareness among Arab women in the United Arab Emirates.